Christine C. Gispen‐de Wied

Medicines Evaluation Board — Netherlands

Medicine · Health Sciences

26h-index2.7kcitations91works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Schizophrenia research and treatment(20), Stress Responses and Cortisol(19), Health Systems, Economic Evaluations, Quality of Life(14), Pharmaceutical Economics and Policy(13), Tryptophan and brain disorders(9)

Publications90 total

Gender differences in the response to antipsychotic medication in patients with schizophrenia: An individual patient data meta-analysis of placebo-controlled studies
Psychiatry Research·2022· 28 citedOpen Access
Sex Proportionality in Pre-clinical and Clinical Trials: An Evaluation of 22 Marketing Authorization Application Dossiers Submitted to the European Medicines Agency
Frontiers in Medicine·2021· 19 citedOpen Access
Assessment of the Regulatory Dialogue Between Pharmaceutical Companies and the European Medicines Agency on the Choice of Noninferiority Margins
Clinical Therapeutics·2020· 5 citedOpen Access
(DATASET, CLEAN) Pathways in the Drug Development for Alzheimer’s Disease (1906-2016): A Bibliometric Study
Figshare·2020Open Access
Run‐in periods and clinical outcomes of antipsychotics in dementia: A meta‐epidemiological study of placebo‐controlled trials
Pharmacoepidemiology and Drug Safety·2019· 10 citedOpen Access
Correction: A standardised framework to identify optimal animal models for efficacy assessment in drug development
PLoS ONE·2019· 19 citedOpen Access
Future of the drug label: Perspectives from a multistakeholder dialogue
British Journal of Clinical Pharmacology·2019· 1 citedOpen Access
Are some animal models more equal than others? A case study on the translational value of animal models of efficacy for Alzheimer's disease
European Journal of Pharmacology·2019· 60 citedOpen Access
A standardised framework to identify optimal animal models for efficacy assessment in drug development
PLoS ONE·2019· 67 citedOpen Access
Alignment of European Regulatory and Health Technology Assessments: A Review of Licensed Products for Alzheimer's Disease
Frontiers in Medicine·2019· 15 citedOpen Access
Baseline imbalances and clinical outcomes of atypical antipsychotics in dementia: A meta‐epidemiological study of randomized trials
International Journal of Methods in Psychiatric Research·2018· 9 citedOpen Access
Oncologic orphan drugs approved in the EU – do clinical trial data correspond with real-world effectiveness?
Orphanet Journal of Rare Diseases·2018· 22 citedOpen Access
Drug Shortages From the Perspectives of Authorities and Pharmacy Practice in the Netherlands: An Observational Study
Frontiers in Pharmacology·2018· 26 citedOpen Access
Ethics in clinical trial regulation: ethically relevant issues from EMA inspection reports
Current Medical Research and Opinion·2018· 9 citedOpen Access
Factors Contributing to the Efficacy-Effectiveness Gap in the Case of Orphan Drugs for Metabolic Diseases
Drugs·2017· 11 citedOpen Access
Early Nonresponse in the Antipsychotic Treatment of Acute Mania
The Journal of Clinical Psychiatry·2016· 9 cited
PM116 An Evidence-Based Practice Team Approach to Health Failure Patient Education
Global Heart·2016
Does Insight Affect the Efficacy of Antipsychotics in Acute Mania?
Journal of Clinical Psychopharmacology·2015· 4 citedOpen Access
Net gain analysis, an addition to responder analysis – The case of antipsychotic treatment of acute mania
Regulatory Toxicology and Pharmacology·2015· 1 cited
Placebo response in antipsychotic trials of patients with acute mania
European Neuropsychopharmacology·2015· 7 cited
page 1 of 5Next →

Frequent Co-authors

Lucres M. C. Jansen(9), Peter J.K. van Meer(8), René S. Kahn(7), Ellen H.M. Moors(7), Huub Schellekens(7), Hubert G. M. Leufkens(7), Michelle Putzeist(6), Aukje K. Mantel‐Teeuwisse(6), Arno W. Hoes(6), Hermán van Engeland(5), Bob Oranje(5), H.G.M. Westenberg(4), Tamar Wohlfarth(4), Jos H.H. Thijssen(4), Marlous Kooijman(3), Dan Cohen(3), H.G.M. Westenberg(3), Barbara J. van Zwieten(3), Jitschak G. Storosum(3), Guilherme S. Ferreira(3)